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Background: Artemin (Artn), a member of the glial cell line-derived growth factor (GDNF) family, supports the
development and function of a subpopulation of peptidergic, TRPV1-positive sensory neurons. Artn (enovin,
neublastin) is elevated in inflamed tissue and its injection in skin causes transient thermal hyperalgesia. A genome
wide expression analysis of trigeminal ganglia of mice that overexpress Artn in the skin (ART-OE mice) showed
elevation in nicotinic acetylcholine receptor (nAChR) subunits, suggesting these ion channels contribute to
Artn-induced sensitivity. Here we have used gene expression, immunolabeling, patch clamp electrophysiology
and behavioral testing assays to investigate the link between Artn, nicotinic subunit expression and thermal
hypersensitivity.
Results: Reverse transcriptase-PCR validation showed increased levels of mRNAs encoding the nAChR subunits α3
(13.3-fold), β3 (4-fold) and β4 (7.7-fold) in trigeminal ganglia and α3 (4-fold) and β4 (2.8-fold) in dorsal root ganglia
(DRG) of ART-OE mice. Sensory ganglia of ART-OE mice had increased immunoreactivity for nAChRα3 and exhibited
increased overlap in labeling with GFRα3-positive neurons. Patch clamp analysis of back-labeled cutaneous afferents
showed that while the majority of nicotine-evoked currents in DRG neurons had biophysical and pharmacological
properties of α7-subunit containing nAChRs, the Artn-induced increase in α3 and β4 subunits resulted in functional
channels. Behavioral analysis of ART-OE and wildtype mice showed that Artn-induced thermal hyperalgesia can be
blocked by mecamylamine or hexamethonium. Complete Freund’s adjuvant (CFA) inflammation of paw skin, which
causes an increase in Artn in the skin, also increased the level of nAChR mRNAs in DRG. Finally, the increase in
nAChRs transcription was not dependent on the Artn-induced increase in TRPV1 or TRPA1 in ART-OE mice since
nAChRs were elevated in ganglia of TRPV1/TRPA1 double knockout mice.
Conclusions: These findings suggest that Artn regulates the expression and composition of nAChRs in GFRα3
nociceptors and that these changes contribute to the thermal hypersensitivity that develops in response to Artn
injection and perhaps to inflammation.
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Table 1 Expression of nAChR subunits in ART-OE
trigeminal (TG) and lumbar DRG
nAChR subunit Fold change microrarray Fold change RT-PCR
TG TG DRG
α2 1.06 ND −1.38*
α3 4.84 13.35* 3.98*
α4 0.67, 1.02 NC
α5 0.9 NC
α6 1.38 NC
α7 1.05 NC
α9 1.06 NC
β2 0.92, 0.96, 1.01 NC
β3 3.13, 3.2, 2.06 4.08* NC
β4 1.56 7.68* 2.82*
Microarray data comparing ART-OE (n = 3) and WT (n = 3) mice was validated
using SYBR green qRT-PCR assay. Multiple values in array data indicate number
of times gene was represented on array. RT-PCR assays analyzed RNA isolated
from 3–6 mice. NC = not changed, ND = not done. Asterisk indicates p <0.05.
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The prolonged release and activation of cellular signaling
pathways by growth factors and cytokines contributes to
the sensitization of primary afferents that transmit pain
[1]. The neurotrophic factors, nerve growth factor (NGF)
and artemin (Artn), may have a particularly important role
in this process. Receptors for each of these growth factors,
where Artn binds the receptors GFRα3 and Ret and NGF
binds the receptors p75 and trkA, are expressed by a sub-
set of peptidergic, TRPV1-positive C-fibers. GFRα3/trkA
afferents comprise 20-25% of the trigeminal and dorsal
root ganglia (DRG), are small to medium in size, are heat
responsive and terminate in spinal cord lamina 1 [2,3].
Approximately 80% of these fibers are CGRP positive and
nearly all (95-99%) express the algogenic receptors TRPV1
and TRPA1.
Artn expression is elevated in several inflammatory con-
ditions, which include pancreatic disease, atopic dermatitis
and following UV-irradiation of the skin [4,5]. In rodents,
experimentally induced inflammation of the skin increases
the level of Artn mRNA and this increase parallels the
time course of thermal hyperalgesia [6,7]. Other studies
have shown that injection of anti-Artn antibodies provides
a partial reversal of complete Freund’s adjuvant (CFA)-
induced mechanical hypersensitivity [7]. In addition, cul-
tured DRG neurons grown in the presence of Artn exhibit
enhanced capsaicin-evoked Ca2+ influx and release of
CGRP [8]. Finally, mice that overexpress Artn in skin
keratinocytes (ART-OE mice) and wildtype (WT) mice
injected with Artn exhibit increased sensitivity to chemical
(capsaicin/mustard oil) and thermal stimuli. These be-
havioral changes likely reflect, at least in part, enhanced
expression of TRPV1 and TRPA1 in the DRG of these
mice [6,9,10].
To better understand how Artn affects sensory neuron
properties and its role in inflammatory conditions, we car-
ried out transcriptional profiling of trigeminal ganglia of
the Artn overexpressing mice. Interestingly, a significant
increase in the nicotinic acetylcholine receptor (nAChR)
subunit genes Chrnα3, Chrnβ3, and Chrnβ4 was found,
suggesting nAChR’s contribute to changes in sensitivity
exhibited by these mice. Nicotinic AChRs are excitatory,
pentameric ion channels expressed throughout the central
and peripheral nervous system that are activated by acetyl-
choline [11]. The presence of nAChR subunits in sensory
neurons has been well documented by binding, expression
and functional assays [12-15]. Electrophysiological and
anatomical evidence also place nAChRs primarily in
capsaicin-sensitive, peptidergic Aδ and C fiber afferents
[15,16], suggesting a role for these channels in nociceptive
signaling [17,18]. Consistent with such a role, application
of acetylcholine (ACh), nicotine or other cholinergic ago-
nists applied to the skin, arterial, tongue, nasal or ocular
surfaces elicits burning pain [19-24].Here we show that enhancing the level of skin-derived
Artn increases the expression and activity of nAChRs in
cutaneous neurons and that CFA-induced tissue inflam-
mation does so as well. In addition, peripheral adminis-
tration of nAChR antagonists was found to attenuate
Artn-induced thermal hypersensitivity in ART-OE mice
and mice acutely injected with Artn, suggesting both
short- and long-term consequences of Artn signaling on
cholinergic activity. These findings suggest a new me-
chanism for the regulation of noxious sensation that
links elevation of growth factors with enhanced signaling
in the nicotinic cholinergic system.
Results
Artn increases nAChR subunit expression in sensory
ganglia
Transgenic mice that overexpress Artn in the skin under
control of the K14 keratin promoter exhibit thermal and
chemical hypersensitivity [9,10]. To identify changes in
gene expression that could contribute to this hypersen-
sitivity, transcriptional profiling of trigeminal ganglia (TG)
of wildtype (WT) and ART-OE mice was carried out.
Interestingly, a marked increase in mRNAs encoding the
α3, β3 and β4 subunits of the nicotinic acetylcholine
receptor was found in ART-OE ganglia (Table 1). SYBR
green real time-PCR (RT-PCR) assays used to validate
these increases show that α3, β3 and β4 are increased in
TG of ART-OE mice but only α3 and β4 were increased in
lumbar DRG (L3-L5) (Table 1). This difference in expres-
sion between the TG and DRG may relate to the different
innervation targets in the respective peripheral fields. The
greatest increase in mRNA was measured for α3, which in
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a 1.38-fold decrease in the α2 transcript level in the DRG.
Because Artn specifically binds and activates signaling
pathways downstream of GFRα3, i.e., it does not activate
GFRα1 and GFRα2 [25], a prediction was that changes in
nAChRs would be associated with GFRα3-positive neu-
rons. We therefore used immunolabeling with tyramide
amplification to assess the co-localization of nAChRα3 and
GFRα3 proteins in the trigeminal ganglia of ART-OE and
WT mice (Figure 1). We analyzed expression of nAChRα3
because it showed the greatest increase in the TG of
ART-OE mice. Immunolabeling with GFRα3/nAChRα3
antibodies showed a greater intensity of nAChRα3 labeling
in ART-OE ganglia relative to wildtype control ganglia.
Quantitative analysis of the overlap in GFRα3/nAChRα3
was carried out and showed a 4.74-fold increase in co-
labeled neurons in ganglia of ART-OE mice relative to
ganglia of wildtype mice (n = 3 mice/group, p < 0.05).
Genetic knockout of Artn/GFRα3 signaling reduces nAChR
expression
To further assess the link between Artn and nAChR
subunit expression, we used real time reverse transcrip-
tase assays to measure the relative level of mRNAs
encoding nAChR subunits in ganglia of Artn- and
GFRα3-knockout mice. ART-KO and GFRα3-KO mice,
which are viable and reported to have no loss in sensory
neurons [26-28], had reduced levels of nAChR α3 and
β3 mRNAs (1.3-2.6-fold), but no change in β4 in sen-
sory ganglia (Table 2).Figure 1 Immunolabeling shows nAChRα3 is expressed in GFRα3-neu
more intense compared to WT ganglia (D-F). Quantitative analysis showed
ganglia of ART-OE mice (46%) compared to WT mice (9.7%) (p < 0.05%, Stu
asterisks mark nAChRα3 neurons that are not GFRα3 positive; arrowhead shNeurturin signaling also changes nAChR subunit
transcription
To determine if other growth factors over-expressed in
the skin alter nAChR expression we assayed the relative
level of nAChR mRNAs in TG and DRG of mice that
overexpress the neurotrophin NT3 (NT3-OE) [29] or
neurturin (Nrtn-OE) [30]. NT3-OE ganglia showed no
change in either α3 or β3 (not shown) whereas ganglia of
Nrtn-OE mice had increased α3 (1.37-fold), α6 (1.54-fold)
and β2 (1.27-fold) and decreased β4 (1.48-fold) and α5
(1.39-fold) (n = 3-4 per group, p < 0.05). Thus, Nrtn also
increased α3 but showed changes in several other subunits
that are distinct from those caused by Artn.
Artn overexpression in skin causes functional changes in
nAChRs in cutaneous afferents
While an increase in nAChR subunit expression should be
associated with an increase in functional receptors in cuta-
neous afferents, it was important to confirm this ex-
pectation. We therefore assessed changes in nAChR
properties using patch-clamp electrophysiology. We com-
pared nicotine-evoked currents in DiI-backlabeled cuta-
neous afferents in DRG of wildtype and ART-OE mice.
Two major current types were observed that were distin-
guished by rates of activation and inactivation; a fast
current that activated and inactivated rapidly and a slow
current that activated and inactivated slowly (Figure 2A).
The nicotine concentration range over which fast and
slow currents were activated were comparable, with
EC50’s of 79 and 49 μM, respectively (Figure 2B and C).rons. Labeling of nAChRα3-positive neurons in ART-OE ganglia (A-C) is
the percentage of GFRα3 neurons that express nAChRα3 is greater in
dent’s t test). Arrows indicate GFRα3/nAChRα3 positive neurons;
ows GFRα3 neuron that is nAChRα3 negative.
Table 2 nAChR subunit and TRP ion channel mRNA level
is reduced in sensory ganglia of Artn and GFRα3
knockout mice
Mouse strain/
gene assayed
Fold change
trigeminal
Fold change
DRG
ART-KO
GFRα3 −1.4* −1.23*
Ret NC NC
TRPV1 −1.28* −1.30*
TRPA1 −1.87* NC
AChRα3 −2.12* −1.27*
AChRβ3 −1.58* −1.54*
AChRβ4 NC NC
GFRα3-KO
TRPV1 −1.56* −1.51*
TRPA1 NC −1.30*
AChRα3 −2.61* −1.27*
AChRβ3 −1.15* −1.36*
AChRβ4 NC NC
Fold change in mRNAs using SYBR green RT-PCR analysis of lumbar (L2/3/4)
DRGs or TG. N = 3–6 animals per group. NC, not changed. *P < 0.05.
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fast currents with a peak current density for the slow
current almost an order of magnitude greater than that
for the fast current (Figure 2C). Nicotine-evoked currents
were only detected in a minority (14 of 74) of cutaneous
neurons from WT mice, and the majority of these (13 of
14) were fast currents (Figure 3, Table 3). In contrast,
while the overall increase in the proportion of cutaneous
neurons from ART-OE mice with nicotine-evoked cur-
rents (29 of 89) was not significant, the increase in the
proportion of neurons from ART-OE mice with slow
current (9 of 89) was significant (p < 0.05, Fisher Exact
test).
Because of recent findings that nicotine activates TRPA1
[31], and our own data showing that Artn increases
TRPA1 expression [10], we performed several additional
experiments to further define the nature of the nicotine-
evoked currents in cutaneous neurons. First, we per-
formed concentration-response analysis of both fast and
slow currents in cutaneous neurons (Figure 2B, C). While
the potency of nicotine-induced activation of inward
current in DRG neurons was comparable to that pre-
viously reported for the activation of TRPA1, the kinetics
of activation of the currents we describe are considerably
faster than those previously reported for TRPA1, even at
relatively low concentrations (Figure 2B). Of note, a
second, even more slowly activating current (i.e., see
Figure 2B), most clearly evident at 1 mM nicotine, was
detected in ~30% and ~80% neurons studied from WT
and ART-OE mice, respectively, and may reflect theTRPA1 current previously described. Second, we charac-
terized the pharmacological properties of the fast and slow
nicotine evoked currents (Figure 4). Both current types
were completely blocked by the non-subtype selective an-
tagonist mecamylamine (50 μM). Because the biophysical
properties of the fast current were comparable to those of
α7-subunit containing nAChRs, we assessed the actions of
the α7-selective antagonist, MLA (20 nM). MLA com-
pletely blocked the fast current (Figure 4A), but had no
detectable influence on the slow current (Figure 4B). Be-
cause the heterologous expression of α4β3 subunit con-
taining nAChRs results in a current with biophysical
properties of the slow current in mouse cutaneous neu-
rons [32], we assessed the impact of the α4β3- agonist
cytisine (100 μM). Cytisine activated a slowly activating
current in 4 of 4 neurons tested with a slow current, but 0
of 4 neurons tested with a fast current (p < 0.05). Finally,
to rule out the possibility that the nicotine-evoked cur-
rents involved the activation of TRPA1, we assessed the
impact of the TRPA1 antagonist HC-030031 on nicotine
evoked currents. Surprisingly, HC-030031 completely
blocked the fast current (n = 4, Figure 4A) but import-
antly, had no detectable influence on the slow current
(Figure 4B). A second TRPA1 antagonist was tested on
the fast current, A-967079, but this too completely
blocked the fast current (n = 3; data not shown). While
the results with these TRPA1 antagonists raise several in-
teresting questions, as this was not the focus of the
present study, these questions were not pursued here.
Third, because GFRα3 is present in a subpopulation of
putative nociceptive, peptidergic sensory neurons, we
sought to determine whether there was a differential dis-
tribution of fast and slow currents among cutaneous
neurons. However, because of evidence that DRG neurons
hypertrophy in the ART-OE mouse [10], we did not in-
clude cell body size as a criterion with which to identify
putative nociceptive afferents. Rather, results obtained
with both small and medium neurons were pooled. This
analysis, summarized in Table 3, indicates that both fast
and slow currents are largely restricted to a subpopulation
of IB4 negative cutaneous neurons.
nAChR antagonists block Artn-induced thermal
hyperalgesia
Injection of Artn causes thermal hypersensitivity that lasts
over 24 h [6,7]. To determine if activation of nAChRs con-
tributes to this transient sensitivity we examined the effect
of nAChR antagonists on Artn-induced behavioral hyper-
algesia. Footpads of WT mice were injected with either
Artn alone, the broad-spectrum nAChR antagonist me-
camylamine [33], or both compounds. In WT mice
Artn-induced a heat hypersensitivity that was blocked by
mecamylamine as indicated by normalization of foot with-
drawal latencies (Figure 5A). Mecamylamine injection was
Figure 2 Nicotine evoked currents in acutely dissociated DRG neurons. Nicotine was applied for 500 ms to neurons held at −60 mV via a
fast application system. A. Two types of currents were detected in mouse DRG neurons that were distinguishable based on differences in
activation and inactivation kinetics: A fast current (left) that activated and inactivated rapidly and a slow current (right) that activated and
inactivated more slowly. B. Fast (top traces) and slow (bottom traces) currents were activated by nicotine over a comparable concentration range.
Fast and slow currents were evoked from the same neuron in response to increasing concentrations of nicotine. A third even more slowly
activating current (top trace, right side) was evoked at higher (1000 μM) concentrations of nicotine and was present in most neurons with fast
current as well as a significant number of neurons without either fast or slow current. C. Concentration response data from individual neurons
with fast (n = 26) or slow (n = 16) current were pooled and fitted with a Hill equation to estimate the maximal evoked current and the
concentration at which a current 50% of maximal was evoked (EC50).
Albers et al. Molecular Pain 2014, 10:31 Page 5 of 13
http://www.molecularpain.com/content/10/1/31found to also block the inherent thermal hypersensitivity
exhibited by ART-OE mice (Figure 5B).
Because mecamylamine can cross the blood brain
barrier and has been shown to block TRPA1 channel
activity [31] we determined if hexamethonium, a periphe-
rally restricted (at low concentration) nAChR antagonist,
also blocks Artn-induced thermal sensitivity. Pre-injection
of hexamethonium in footpad skin 30 minutes prior to
Artn injection significantly inhibited Artn-induced heathypersensitivity for up to 5 h (Figure 5C). Thus, blocking
nAChR signaling inhibits behavioral thermal hypersensi-
tivity caused by Artn injection into the skin.
Peripheral inflammation increases nAChR α3 and β4 gene
expression in DRG
Inflammation of the skin induced by CFA injection in-
creases the level of Artn mRNA [6,7]. Based on the
above results, the elevation in Artn predicts an increase
Figure 3 Nicotine-evoked current density. Current density was
determined by dividing the peak-evoked current in response to
300 μM nicotine by the membrane capacitance. Pooled data from
neurons with fast and slow current indicate that the slow current
density is significantly greater than that of the fast current. The
proportion of neurons from wild type (WT) and ART-OE (OE) mice
with evoked current that was either fast or slow is indicated above
each bar.
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analysis of RNA isolated from DRG of CFA injected mice
does show increases in α3 and β4 mRNAs (1.5-fold at 1d
and 2.1-fold at 3d post CFA, respectively) (Figure 6). No
change in β3 mRNA was detected at these time points,
which is consistent with the finding that β3 is unchanged
in DRG of ART-OE mice (Table 1).
Increased nAChR expression by Artn is independent of
TRPV1 or TRPA1 activity
The enhanced expression of nAChR subunits and the ion
channels TRPV1 and TRPA1 in ganglia of ART-OE mice
raises the possibility of regulatory interactions between
these receptor types. For example, increased expressionTable 3 Properties of nicotinic responder neurons from WT (n
binding, size and capsaicin sensitivity
Strain Total cells IB4+ IB4-
Wildtype 74 29 39
With current 14 0 14
No current 60 29 25
Fast current 13 0 13
Slow current 1 0 1
ART-OE 89 13 28
With current 29 1 17
No current 60 12 19
Fast current 20 1 14
Slow current 9 0 4and activity of TRP channels may alter cell signaling path-
ways and lead to increased expression of nAChRs or vice
versa. To investigate this possibility we used RT-PCR to
measure the relative level of nAChR mRNAs in DRG
of hybrid ART-OE/TRPV1−/−/TRPA1−/− mice, generated
by crossing ART-OE mice with TRPV1/TRPA1 double
knockout mice (Table 4). Results show that even in the
absence of TRPV1 and TRPA1 function, nAChR gene ex-
pression is elevated in DRG of ART-OE mice. Thus, the
increase in nAChRs in response to Artn is not dependent
on TRP signaling.
Discussion
In this study we report that Artn, a growth factor that is
elevated in inflamed tissue, increases nAChR subunit
transcription in a subunit specific manner. This increase
correlated with functional changes in nAChR response
properties in DRG neurons and contributed to Artn-
induced thermal hypersensitivity. Changes in nAChR
subunit expression and nicotine-evoked current primarily
affected the peptidergic, GFRα3-positive DRG neuron
subpopulation, which is consistent with findings of Flores
and colleagues [14], who showed using in situ hybri-
dization that α3 and β4 are co-expressed in medium-
diameter neurons. This observation is also consistent with
Spies et al. [34] who reported small- to medium-sized
neurons express the α3 nAChR subunit. In addition,
since ~95% of GFRα3 neurons are TRPV1-positive, the
overlap in GFRα3/nAChRα3 labeling is consistent with
work of Dussor et al. [12], who showed overlap of
TRPV1 and nAChRα3 mRNAs, and studies of Roberts
et al., and Rau et al., who used patch clamp analysis of
isolated neurons to show functional overlap of nAChR
and TRPV1 activity [15,16].
Functional analysis of cutaneous DRG neurons from
wildtype and ART-OE mice revealed three populations
of neurons based on their response to nicotine: those
with no current (at least to nicotine < 300 μM), and= 6) and ART-OE (n = 7) mice defined by IB4 lectin
Small Medium Cap pos Cap neg
61 13 11 36
5 9 2 5
56 4 9 31
5 8 - -
1 0 - -
71 18 13 27
19 10 - -
52 8 - -
14 6 - -
6 3 - -
Figure 4 Pharmacological characterization of nicotine evoked currents. A. The fast current was blocked by the non-specific nicotinic receptor
antagonist mecamylamine (Mec, top trace), the α7-subunit antagonist MLA (middle trace) and the TRPA1 “selective” antagonist HC-30031 (HC, bottom
traces). Currents are from three different neurons in response to nicotine applied with a 5 min inter-stimulus interval before and after the application
of antagonist. B. The slow current was also blocked by Mec (top row) but was resistant to MLA (second row) and activated by the α4β3 agonist cytisine
(third row). The slow current was also resistant to HC-30031. As in A, current in each row was evoked from a different neuron. All data in A and B were
from ART-OE mice, but comparable data for the fast current were obtained from WT mice.
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current had biophysical properties consistent with those
of α7-subunit containing nAChRs while properties of
the slow current were comparable to α3/β4-subunitcontaining nAChRs [35]. With the exception of the ob-
servation that fast currents were blocked by two TRPA1
antagonists, the pharmacological sensitivity of the fast
and slow currents were consistent with those of α7- and
Figure 5 nAChR antagonists block Artn-induced heat hyperalgesia.
A. WT (n = 4) and ART-OE (n = 6) mice were injected with either 10 μl
saline (right foot) or 10 μl Mec (left foot, 1 mg/kg) and latencies of
withdrawal measured for each foot 60 min post injection. As previously
reported [10], ART-OE mice exhibit lower heat thresholds compared
with WT mice (compare saline treated groups). Mec partially blocks
heat hyperalgesia in ART-OE mice (p < 0.05, ANOVA) and did not affect
thermal sensitivity in WT mice. B. Footpads of WT mice were injected
with 1 mg/kg Mec or saline 30 min prior to injection of Artn (200 ng)
or saline. Mec injection had no effect on thermal sensitivity. Artn
injection alone increased heat hyperalgesia whereas Mec + Artn
blocked hyperalgesia. C. Mice (n = 6) were injected in the left footpad
with saline (10 μl) 30 min prior to Artn injection (200 ng). Other mice
(n = 6) were injected with HEX (10 μl, 1 mg/kg) followed by Artn. A
third set (n = 6) were injected with HEX followed by saline. HEX alone
did not affect thermal sensitivity. HEX blocked thermal sensitivity
caused by Artn at 1 h, 3 h and 5 h post injection. Measures were made
in a blinded manner. Asterisks indicate p < 0.05.
Figure 6 CFA-induced skin inflammation increases nAChR
mRNA levels in DRG. The percent of baseline expression of nAChR
mRNAs in lumbar DRG of uninjected mice (n = 5) and CFA injected
mice (n = 6) was compared using SYBR green qRT-PCR at 1 d and
3 d post injection of CFA into footpads of C57BL/6 J mice. Percent
change normalized to gapdh is plotted. Asterisks indicate significant
change in β4 at day 1 and α3 at day 3 (two-way ANOVA with
Bonferroni posttests with p < 0.05).
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rents were blocked by the α7-selective antagonist MLA
and slow currents were activated by the α3/β4 agonist
cytisine. Consistent with the changes in subunit expres-
sion, the percentage of neurons from ART-OE and WT
mice with a fast current was equivalent, whereas slow
currents were significantly more prevalent among neu-
rons from ART-OE mice (9 of 89 neurons) compared to
WT mice (1 of 74 neurons).
The distribution of fast and slow currents was also
consistent with their expression in neurons that express
GFRα3: both current types were found only in IB4-
negative neurons. This observation raises the possibility
that changes in nAChR gene expression are directly reg-
ulated by Artn activation of GFRα3 signaling pathways.
While another possibility is that this shift reflects in-
creased survival of neurons exhibiting slow current inTable 4 Artn-induced changes in nAChR subunit
transcription occur in the absence of TRPV1 and TRPA1
activity
Mouse strain nAChRα3 nAChRβ4 nAChRβ3
TG DRG TG DRG TG DRG
ART-OE 13.35* 3.99* 7.68* 2.83* 4.08* NC
ART-OE x TRPV1−/−/TRPA1−/− 12.42* 2.36* 6.69* 2.22* 3.53* NC
Values are expressed as fold-change relative to WT ganglia. NC, not changed.
Asterisk indicates significant difference with p < 0.05.
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gesting that there is an increase in the proportion of
neurons with slow current in the presence of persistent
inflammation argues against this possibility [36].
Changes in nAChR subunit expression also were mea-
sured in ganglia of Nrtn-OE mice. Although there was
some overlap in the pattern of subunit expression, Nrtn
caused a change in nAChRs distinct from that detected
in ganglia of ART-OE mice. This suggests that signaling
pathways activated downstream of each GFRα receptor
can modulate changes in nAChR expression. Further-
more, there is evidence that other growth factors re-
gulate nAChR subunit expression: neuregulin 1 signaling
through the ErbB kinase receptor increases nAChRs in
developing skeletal muscle [37] and increases α3 and β4
mRNA in pelvic ganglion neurons [38]. In addition, cul-
tured PC12 cells treated with NGF exhibit increased
nicotinic current density and mRNAs that encode
nAChRs α3, α5, α7 β2, β4 [39]. With respect to NGF, it is
of interest to note that most GFRα3-positive neurons ex-
press receptors for NGF, a well-characterized inflamma-
tory mediator. This co-responsiveness is likely to have
functional significance; in previous studies we showed a
synergistic interaction between Artn and NGF, where a
single injection of each factor produced a transient (24 h)
heat hyperalgesia but coinjection of Artn and NGF pro-
duced hyperalgesia that lasted for more than 6 days [6].
That both NGF and Artn can increase in inflamed tissue
and both can modulate nAChR expression suggests the
complex interplay between these factors that leads to
long-term activation of the GFRα3-positive population
could involve changes in cholinergic signaling.
For Artn, identifying which of the numerous GFR sig-
naling cascades such as src, PKA, PLC and MAPKs [40]
that could potentially influence nAChR gene transcription
will require further study. Nevertheless, the fact that
heterogeneity in nAChR subunit composition is largely
responsible for heterogeneity in nAChR signaling suggests
the subpopulation-specific expression of nAChRs could
contribute to the unique functional properties exhibited
by GFR- and trk-positive neuronal subtypes [10,30,41].
That mecamylamine and hexamethonium reduce ther-
mal sensitivity in ART-OE mice and WT mice injected
with Artn, suggest that nAChR activity contributes to
thermal sensitivity. Preliminary data suggest ACh levels
are elevated in CFA inflamed skin (at 3 d post CFA injec-
tion a 1.46-fold increase in ACh was measured in inflamed
skin relative to skin of naïve mice (CFA 8.9 μg/ml vs. naive
4.7 μg/ml supernatant; n = 3 CFA mice and 2 naïve mice)).
ACh is also elevated in human skin conditions such as
atopic dermatitis [42]. The increase in ACh raises the pos-
sibility that endogenous ACh could contribute to per-
sistent depolarization of nociceptive afferents. Persistent
depolarization would require the slowly inactivating α3β4-type channels increased by Artn and could account for
the increased sensitivity to thermal stimuli [10]. While the
fast currents should also contribute to activation of noci-
ceptive afferents, the persistent α3β4-type channels are
also likely to contribute to the aversive responses elicited
by ACh, nicotine and other cholinergic agonists applied to
the skin, arterial, tongue, nasal, or ocular surfaces [21-24].
Consistent with the suggestion that nicotine can generate
a persistent depolarizing drive in nociceptive afferents, in
a rat skin-saphenous nerve preparation, nicotine not only
induced a dose-dependent activation of C-fibers, but sen-
sitized them to heat stimulation [43]. Such a mechanism
could also account for the well established link between
smoking and the severity of chronic pain conditions, such
as lower back pain [44], diabetic neuropathy [45,46], fibro-
myalgia and pancreatitis [47]. The presence of nAChRs on
peptidergic afferents also suggests that these channels
contribute to the regulation of the efferent function of
these afferents, e.g., transdermal iontophoresis of ACh in
humans causes flare by neuropeptide release which can be
blocked by hexamethonium [48].
Previous studies of ART-OE mice have shown elevation
of TRPV1 and TRPA1 mRNAs in GFRα3-neurons and be-
havioral sensitivity to their respective agonists, capsaicin
and mustard oil. Because functional interactions between
TRPV1, TRPA1 and nAChR channels are reported in
DRG neurons [31,49,50], we explored a possible inter-
action between the increase in nAChR subunits and TRP
gene expression using ART-OE x TRPV1−/−/TRPA1−/−
hybrid mice. Results show that even in the absence of
functional TRPV1 and TRPA1, Artn overexpression in
skin increased transcription of mRNAs encoding α3 and
β4 to levels equivalent to those in ART-OE mice. There-
fore, the elevation in nAChRs is not a compensatory re-
sponse to the increase in TRPV1 and TRPA1 in GFRα3
neurons and suggests a more direct role for Artn in
nAChR regulation.
While we have focused on the role of peripheral
nAChRs in the present study, changes in receptor density
or function at central afferent terminals may also occur. In
contrast to the pronociceptive role for nAChR signaling
in peripheral terminals, the majority of studies using
systemic or intrathecal delivery of nAChR agonists show
spinal nAChR activation is antinociceptive [11,51-53].
Antinociception may result from changes in neurotrans-
mitter release at presynaptic terminals and/or activation
of descending noradrenergic and serotonergic systems
[54,55]. Our behavioral and pharmacological data does
not rule out the possibility of altered spinal presynaptic or
descending signaling in response to long-term changes in
Artn level in the periphery. Indeed, repeated injection of
Artn was reported to block hyperalgesia and normalize
neurochemical changes related to nerve injury in a rat
model [56]. In addition, Artn (neublastin) is currently in
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[57]. In this preliminary study, some subjects reported a
higher reduction in pain compared to placebo treated
subjects. However, several subjects also reported mild to
moderate adverse events that included headache, feeling
hot, generalized pruritus and burning sensations. These
events may result from the known effects of Artn on
TRPV1 and TRPA1 expression and perhaps, as indicated
by results of this study, on nAChR signaling as well.
Conclusions
In chronic inflammatory conditions, increased expression
of growth factors such as Artn is thought to alter gene
expression and functional properties of sensory afferents.
These changes can lead to increased neuron excitability
that results in hypersensitivity. In mice that overexpress
Artn in the skin, a significant increase in mRNAs en-
coding nAChR subunits α3, β3 and β4 and changes in
nicotinic response properties in cutaneous afferents were
observed. Thermal sensitivity evoked by Artn overexpres-
sion or by acute injection of Artn into footpad skin could
be blocked by peripheral delivery of nicotinic antagonists.
These findings indicate that the rise in Artn expression in
inflamed tissue may regulate in a subunit specific manner,
the expression of nAChR genes in primary afferents. This
change in expression may contribute to changes in
afferent properties that lead to hypersensitivity commonly
associated with chronic inflammation.
Methods
Animals
Male and female artemin overexpresser (ART-OE) trans-
genic mice (described in Elitt et al. [10]) and strain and
age-matched control littermates were used in these stu-
dies. ART-OE mice express a transgene in which the K14-
keratin promoter drives expression of Artn in keratino-
cytes of the skin and oral cavity epithelium. For the CFA
and Artn injection studies, 8–10 wk-old male, C57BL/6 J
mice (Jackson Laboratories, Bar Harbor, ME) were used.
Animals were housed in an American Association for the
Accreditation of Laboratory Animal Care-accredited fa-
cility in a temperature and humidity controlled room on a
12 h light/12 h dark cycle with food and water provided
ad libitum. Procedures were carried out in accordance
with the guidelines of the University of Pittsburgh Institu-
tional Animal Care and Use Committee.
Chemicals and drugs
Rat Artn was generously provided by Biogen Idec (Weston,
MA). Allyl isothiocyanate (AITC), capsaicin (CAP), cyti-
sine, HC-030031, nicotine, hexamethonium, mecamyla-
mine, methyllycaconitine (MLA) were purchased from
Sigma-Aldrich (St. Louis, MO). Compound A-967079 was
a generously supplied by AbbVie (North Chicago, IL).Artn was dissolved in saline at 200 ng/ml and 20 μl
injected into footpad skin. For in vivo use mecamylamine
and hexamethonium were dissolved in saline and 10 μl
injected in footpad skin at 1 mg/kg body weight. These
doses were chosen based on previous studies [6,58,59].
For in vitro studies mecamylamine was used at 50 μM and
nicotine was used at concentrations between 1 μM and
3 mM. The α7 nAChR subunit antagonist MLA was dis-
solved in saline and used at a concentration of 20 nM.
The TRPA1 antagonist HC-030031 was dissolved in
DMSO at a concentration of 10 mM and diluted in bath
solution to a final concentration of 10 μM based on results
of prior studies [60]. The α3β4 nAChR subunit agonist
cytisine was dissolved in normal bath solution and applied
at a concentration of 100 μM [61]. The TRPV1 selective
agonist capsaicin was dissolved in ethanol at a concentra-
tion of 10 mM and diluted in bath solution to a final con-
centration of 500 nM [62].
Genome wide expression analysis
Mouse WG-6 Expression BeadChips (Illumina, San Diego,
CA) were used to compare genes expressed in trigeminal
ganglia of wildtype (C3HB6 hybrids) and ART-OE mice
(n = 3 per group). In vitro transcription labeling, hybri-
dization and data analysis was carried out by the Uni-
versity of Pittsburgh Genomics and Proteomics Core
Laboratories (http://www.genetics.pitt.edu/).
Reverse transcriptase real time PCR analysis
1 μg of RNA isolated from either pooled trigeminal or
L2-L4 DRG was DNase-treated (Invitrogen Corporation,
Carlsbad, CA), reverse-transcribed using Superscript II
(Invitrogen Corporation, Carlsbad, CA) and analyzed
using SYBR green PCR following manufacturers protocols.
PCR primers (Table 5) were designed using MacVector
software or software provided by Integrated DNA Tech-
nologies (Coralville, Iowa). SYBR green-PCR amplification
reactions were performed on an Applied Biosystems 7000
real-time thermal cycler controlled by Prism 7000 SDS
software (Applied Biosystems, Foster City, CA). Duplicate
threshold cycle (Ct) values were used as a measure of
initial template concentration. Relative fold change in
RNA was calculated using the ΔΔCt method using glycer-
aldehyde-3-phosphate dehydrogenase (Gapdh) as a refe-
rence standard. Statistical significance between calculated
ΔΔCt values determined using Student’s t-test with signifi-
cance set a p < 0.05.
Tissue immunolabeling
Overlap of GFRα3 receptor and nAChRα3 expression in
trigeminal ganglia of WT and ART-OE mice was de-
tected using immunolabeling with tyramide signal amp-
lification (Perkin Elmer, Waltham, MA). Ganglia from
animals (n = 3 mice per group) perfused with 4%
Table 5 List of PCR primers used in this study
Gene Primer pair (5′→3′)
CHRNA2 GTGCCCAACACTTCCGATGT; CCAGCGCAGCTTGTAGTCAT
CHRNA3 TCCTGTCATCATCCAGTTTGAGG; TCATTCCAGATTTGCTTCAGCC
CHRNA4 CGCTTTGGCTTGTCGATTGC; AGTTTGTAGTCATGCCACTCCT
CHRNA5 GAAGGGGCCAGTACGAAAACA; AGCCGAATTTCATGGAGCAAT
CHRNA6 TAAAGGCAGTACAGGCTGTGA; AAAATGCACCGTGACGGGAT
CHRNA7 CACATTCCACACCAACGTCTT; AAAAGGGAACCAGCGTACATC
CHRNA9 GGAACCAGGTGGACATATTCAAT; GCAGCCGTAGGAGATGACG
CHRNB2 GAGGTGAAGCACTTCCCATTT; GCCACATCGCTTTTGAGCAC
CHRNB3 CAAAGGGGATGAAGGGCAAC; AAAGAGGGTGTAAAACAGGGGC
CHRNB4 TGGATGATCTCCTGAACAAAACC; CAGGCGGTAGTCAGTCCATTC
TRPV1 TTCCTGCAGAAGAGCAAGAAGC; CCCATTGTGCAGATTGAGCAT
TRPA1 GCAGGTGGAACTTCATACCAACT; CACTTTGCGTAAGTACCAGA
GTGG
GAPDH ATGTGTCCGTCGTGGATCTGA; GCTGTTGAAGTCGCAGGAGACA
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(PB) were post-fixed 2 h in 4% PFA at room temperature
(RT). Ganglia were cryoprotected in 25% sucrose in
0.1 M PB overnight at 4°C, embedded in OCT compound
(ThermoFisher Scientific) and sectioned at 20 μm thick-
ness on a cryostat. Sections were washed in PB and
incubated in rabbit anti-nAChRα3 (1:100, Santa Cruz
Biotechnology, CA) in phosphate buffered saline (PBS)
and 0.25% Triton X-100 at RT. Incubation times ranged
from 8 h to overnight. Sections were washed, treated with
0.01% hydrogen peroxide solution in PBS for 30 min,
washed and incubated 1 h at RT in horse radish pero-
xidase conjugated donkey anti-rabbit IgG (1:1000; Jackson
ImmunoResearch, West Grove, PA). Sections were washed,
incubated in rhodamine-conjugated AMP reagent (diluted
1:50 with kit reagent) for 10–20 minutes. Sections were
then washed, incubated in goat anti-GFRα3 (R&D Systems,
CA) 6 h-18 h, washed and then incubated in donkey anti-
goat Cy2 (1:500; Jackson ImmunoResearch). Sections were
washed, coverslipped in antifade solution (90% glycerol
containing n-propyl gallate; see http://www.jacksonimmuno.
com/technical/anti-fade.asp) and images captured using a
digital camera attached to a Leica DM4000B fluorescence
microscope (Leica, Wetzlar, Germany). Images captured
from 5 non-overlapping sections of ganglia from 3 WT and
3 ART-OE mice were analyzed to determine the percentage
of GFRα3-positive neurons that also exhibited staining for
nAChRα3. All tissue processing, antibody labeling, image
capture and processing were done in parallel. Statistical
analysis of the data were done using Student’s t test with sig-
nificance set at p < 0.05.
Behavioral testing
Behavioral measures were made using a plantar testing
apparatus (IITC, Woodland Hills, CA) in a blindedmanner in the University of Pittsburgh Rodent Behavior
Analysis Core. Animals were acclimatized for 1 h in the
thermal testing apparatus for 2 days prior to testing. At
30 min following Artn or drug injection animals were
placed individually in a small plexiglass enclosure with a
glass floor. A focused light beam was applied to the
plantar surface of the back feet. The mean of three mea-
sures of withdrawal latencies was determined at each
timepoint tested. Data were analyzed using GraphPad
Prism 4 software (San Diego, CA) and are presented as
the mean ± SEM. Statistical analyses for differences over
time in multiple groups were performed using two-way
ANOVA followed by the Holm-Sidak post hoc test with
significance set at p < 0.05.
CFA inflammation
Mice were anesthetized with isoflurane and 20 μl of
complete Freund’s adjuvant (CFA) emulsion was injected
into the plantar surface of the hindpaw. All mice showed
substantial edema after CFA injection. At day 0, 1 d and
3 d post-injection mice were deeply anesthetized and per-
fused transcardially with cold 0.9% saline. Paw skin and
L3-L5 DRG were collected on dry ice and immediately
processed for RNA isolation using Trizol reagent and
RNeasy columns (Qiagen Inc., Valencia, CA), respectively.
RNA was reconstituted in RNase-free water and processed
for real time-PCR analysis.
Patch clamp electrophysiology
DRG neurons that innervate the hind paw glabrous
skin of WT and ART-OE mice were retrogradely labeled
with 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbo-
cyanine perchlorate (DiI). L4 and L5 DRGs were enzyma-
tically treated, mechanically dissociated and cultured as in
[10]. Neurons were analyzed at 2–24 hours after dis-
sociation. Voltage-clamp data were acquired with con-
ventional whole cell patch clamp techniques with an
Axopatch 200B amplifier (Molecular Devices, Sunnyvale
CA) controlled with a PC running pClamp Software
(V 10.3, Molecular Devices). Current traces were sampled
at 5–10 kHz and filtered at 1–2 kHz. Patch electrodes
were pulled from borosilicate glass (WPI, Sarasota FL) on
a horizontal puller (Sutter Inst. Novato CA), and were 2–
3 MΩ when filled with an electrode solution containing
(in mM): K-methanesulfonate 110, KCl 30, NaCl 5, CaCl2
1, MgCl2 2, HEPES 10, EGTA 11, Mg-ATP 2, Li-GTP 1;
pH 7.2 (adjusted with Tris-base), 310 mOsm (adjusted
with sucrose). Currents were recorded in a bath solution
containing (in mM): KCl 3, NaCl 130, CaCl2 2.5, MgCl2
0.6, HEPES 10, glucose 10; pH 7.4 (adjusted with Tris-
base), 325 mOsm (adjusted with sucrose). The junction
potential associated with all test solutions was measured
and were all less than 5 mV, and therefore, junction poten-
tial was not corrected. Series resistance compensation
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were compensated with amplifier circuitry. Neurons were
held at −60 mV and nicotine, cytisine, CAP and AITC
were applied with a piezo- driven perfusion system
(Warner Instruments, Hamden CT). Subpopulations of
DRG neurons were defined by cell body size, binding of
the plant lectin IB4 and responsiveness to CAP.
Current data were analyzed with pClamp software in
combination with SigmaPlot (Systat, Chicago, IL). Current
density was determined by dividing peak-evoked current
by membrane capacitance (as determined with a 5 mV
voltage step prior to compensation). Concentration-re-
sponse data were fitted with a Hill equation to generate
estimates of peak current (efficacy), the concentration 50%
of peak (EC50, potency), as well as the Hill coefficient.
Measure of acetylcholine
Footpad skin from C57BL/6 J mice injected 3 days prior
with complete Freund’s adjuvant was immediately homo-
genized in PBS using a polytron (Kinematica AG). Equi-
valent amounts of supernatant (based on initial tissue
weight) were assayed using the Amplex Red Acetyl-
choline/Acetlycholinesterase assay kit (Life Technologies,
Molecular Probes). Fluorescence intensity was measured
using a multiwell fluorescent plate reader (Gemini XPS;
Molecular Devices, Sunnyvale, CA; excitation wavelength
560 nm and emission 590 nm) and μg/ml calculated using
a standard curve.
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